期刊文献+

N-端脑钠素前体与心钠素对冠心病慢性心力衰竭诊断及预后判断价值的比较研究 被引量:5

Comparison study on diagnostic and prognostic value of Nterminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure
下载PDF
导出
摘要 目的比较N-端脑钠素前体(NT-proBNP)和心钠素(ANP)对冠心病慢性心力衰竭(心衰)的诊断及预后判定价值。方法入选118例冠心病患者,其中伴心衰78例,无心衰40例。用电化学发光法测定血浆NT-proBNP,用放射免疫法测定血浆ANP,并与40例正常人进行比较。定期随访、记录冠心病患者心脏事件的发生情况。结果心衰患者血浆NT-proBNP和ANP浓度均显著高于无心衰患者及正常人组(P均<0.05)。心功能IV级者NT-proBNP浓度显著高于心功能Ⅱ、Ⅲ级者,血浆ANP浓度显著高于心功能Ⅲ级者,但与Ⅱ级者比较差异无显著性。血浆NT-proBNP和ANP对于冠心病心衰诊断的敏感性分别为91.25%和73.46%;特异性分别为90.25%和80.33%。心衰组中死亡者与存活者血浆NT-proBNP和ANP水平差异无显著性。结论NT-proBNP对冠心病心衰的诊断价值高于ANP,二者均与冠心病心衰患者短期心源性死亡无关。 Objective To investigate the diagnostic and prognostic value of nterminal-probrain natriuretic peptide(NT-proBNP) and atrium natriuretic peptide (ANP)in chronic congestive heart failure. Methods One hundred and eighteen coronary heart disease patients were enrolled in the study. Among them 78 patients were accompanied by heart failure and 40 with no heart failure. Plasma NT-proBNP was determined with Elecsys Chemiluminescence Immunoassay method, and plasma ANP was determined with radioimmunoassay method.The results were compared with those of 40 healthy in dividuals. All patients were followed up accordingly. Results Compared with patients with no heart failure and healthy individuals, the patients with heart failure had a higher plasma NT-proBNP and ANP contents (P〈0.05). Cardiac function grade IV patients had a significantly higher plasma NT-proBNP than cardiac function grade Ⅱ and Ⅲ patients,and their plasma ANP level was significanthy higher than that of cardiac function grade Ⅲ patients,but there was no significantly difference in ANP content between cardiac function grade Ⅳ and Ⅱ.The diagnostic sensitivity of NT-proBNP and ANP was 91.25% and 73.46%, respectively. The diagnostic specificity of NT-proBNP and ANP was 90.25%, 80.33%, respectively. In the heart failure group, it was found that there was no significant difference in the plasma NT-proBNP and ANP between the deaths and surviving patients. Conclusion The diagnostic value of NT-proBNP in chronic heart failure is higher than that of ANP.According to our followup result,the plasma NT-proBNP and ANP can not be relied up on to predict short -term cardiogenic death in heart failure.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第9期1740-1742,共3页 Journal of Southern Medical University
关键词 心力衰竭 充血性 N-端脑钠素前体 心钠素 chronic congestive heart failure nterminalpro brain natriuretic peptide atrium natriuretic peptide
  • 相关文献

参考文献4

  • 1Richard WT, Chridtopher MF, Timothy GY, et al. Treatment of heart failure guided by plasma aminoterm in albrain natriuretic peptide (NBNP)concentrations[ J]. Lancet, 2000, 355(8): 1126-8.
  • 2Clerico A, DelRy S, Giannessi D. Measurement of cardiac natriuretic hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new gene ration of immunoassay methods [J]. Clin Chem, 2000, 46(9): 1529-32.
  • 3Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria[J]. Circulation, 2000, 101(11): 2118-9.
  • 4尹力,李广平,李健,李立丰,张承宗,黄体钢.急性心肌梗死死亡及再梗死相关因素的分析[J].中国危重病急救医学,2003,15(8):465-468. 被引量:20

二级参考文献9

  • 1Lee K L, Woodlief L H,Topol E J,et al. Predictors of 30 -day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41 021 patients:GUSTO - I investigators[J]. Circulation, 1995,91 :1659 - 1668.
  • 2Brener S J, Ellis S G, Sapp S K,et al. Predictors of death and reinfarction at 30 days after primary angioplasty:the gusto Ⅱ b and rapport trials[J]. Am Heart J, 2000,139: 476 - 481.
  • 3Benhorin J,Moss A J,Oakes D,et al. Prognostic significance of nonfatal myocardial reinfarction [J]. J Am Coll Cardiol, 1990,15 :253 -259.
  • 4Burns R J, Gibbons R J, Yi Q, et al. The relationships of left ventricular ejection fraction, end -systolic volume index and infarct size to six- month mortality after hospital discharge following myocardial infarction treated by thrombolysis [J].J Am Coll Cardiol, 2002,39 : 30 - 36.
  • 5Bode C,Smalling R W, Sen S,et al. Recombinant plasminogen activator angiographic phase Ⅱ international dose finding study ( RAPID ): patency analysis and mortality endpoints [J].Circulation,1993,88(Suppl I :292-301.
  • 6Elad Y,French W J,Shavelle D M,et al. Primary angioplasty and selection bias in patients presenting later (>12 h) after onset of chest pain and ST elevation myocardial infarction[J]. J Am Coll Cardiol, 2002,39 : 826 - 833.
  • 7Ottervanger J P, Liem A, De Boer M J, et al Limitation of myocardial infarct size after primary angioplasty: is a higher pateney the only mechanism[J]? Am Heart J, 1999,137,1169 -1172.
  • 8Qiu Y,Tang X L,Park S W,et al. The early and late phases of ischemic preconditioning:a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40- minute coronary occlusion[J].Circ Res, 1997,80 : 730 - 742.
  • 9苏绍萍,沈洪,王禹,孟庆义,计达.急诊院前猝死事件的发生特点[J].中国危重病急救医学,2001,13(3):162-163. 被引量:19

共引文献19

同被引文献39

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部